Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Assembly Biosciences
(NQ:
ASMB
)
14.41
UNCHANGED
Streaming Delayed Price
Updated: 3:28 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Assembly Biosciences
< Previous
1
2
3
Next >
ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Insiders Buying American Software And 2 Other Stocks
July 09, 2024
Via
Benzinga
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
May 13, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
March 28, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023
March 25, 2024
ASMB stock results show that Assembly Biosciences missed analyst estimates for earnings per share the second quarter of 2023.
Via
InvestorPlace
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 12, 2023
Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Via
Benzinga
Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection
July 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 18, 2023
Via
Benzinga
Crude Oil Moves Lower; Bank of America Profit Beats Expectations
October 17, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Via
Benzinga
Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings
October 17, 2023
U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Are Stocks Down Today?
October 17, 2023
Stocks are down today, and investors wondering why are in the right place as we have all the details they need to know about on Tuesday!
Via
InvestorPlace
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
October 17, 2023
Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!
Via
InvestorPlace
Nasdaq Down Over 1%; US Retail Sales Top Expectations
October 17, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Tuesday. Following the market opening Tuesday, the Dow traded down 0.11% to 33,947.98 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why
October 17, 2023
Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
Via
Benzinga
Assembly Biosciences Shares Gain After Promising Early Cut Data From HBV Infection Programs
December 19, 2022
Assembly Biosciences Inc (NASDAQ: ASMB) announced interim efficacy, safety, and pharmacokinetic (PK) results from a Phase 1b study of ABI-H3733 (3733) and a Phase 1a study of ABI-4334 (4334).
Via
Benzinga
NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82%
October 24, 2022
Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
October 24, 2022
Upgrades
Via
Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Penny Stocks That Could Triple in 2022
June 22, 2022
Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns.
Via
InvestorPlace
Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection
June 06, 2022
Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic Hepatitis B Virus Infection
Via
Benzinga
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
May 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.